Diabetes development more likely for those with higher glycemic level, BMI ≥30 kg/m2 and among Black versus White individuals
FRIDAY, March 11, 2022 (HealthDay News) — Six percent of individuals with prediabetes develop diabetes within one year, according to a study published online March 2 in the Journal of General Internal Medicine.
Eva Tseng, M.D., M.P.H., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues describe the clinical care of individuals with prediabetes and examined patient factors associated with this care in a retrospective cohort study using linked claims and electronic health record data. The cohort included 3,888 adults with prediabetes based on laboratory measures.
The researchers found that 63.4 percent of patients had repeat glycemic testing within 12 months, but only 10.4, 1.0, and 5.4 percent had coded diagnoses of prediabetes, were referred for nutrition services, and were prescribed metformin. When referred, most patients completed labs and nutrition visits; most patients filled metformin when prescribed. The likelihood of receiving prediabetes clinical care was increased for individuals with a higher glycemic level or body mass index (BMI). Within 12 months of cohort entry, 6 percent of individuals developed diabetes, and they had higher glycemic levels and BMI ≥30 kg/m2. Compared with White individuals, Black individuals had 1.4 times higher odds of developing diabetes in the adjusted model.
“Strategies to improve prediabetes diagnosis, Diabetes Prevention Programs and nutrition referrals, and metformin prescribing are urgently needed to improve prediabetes care delivery with the goal of preventing or delaying incident diabetes,” the authors write.
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD
Type 2 Diabetes Linked to Worse Menopausal Symptoms
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk
Gaining an Hour of Sleep May be Protective Against Retinal Disease
Renal Impairment Linked to Age-Related Macular Degeneration
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy